New York A05840 requires inpatient facilities to provide opioid reversal drugs to at-risk individuals upon discharge.

New York A05840 amends the public health law and the mental hygiene law to mandate that inpatient facilities dispense at least two doses of opioid reversal drugs to individuals at risk for a substance use disorder upon discharge. This applies to those with documented substance use disorders or those appearing at risk, ensuring they have access to necessary medications to prevent opioid overdoses. The bill aims to enhance patient safety and support recovery efforts by providing immediate access to life-saving drugs.

New York A05840 requires inpatient facilities to provide opioid reversal drugs to at-risk individuals upon discharge.

New York A05840 amends the public health law and the mental hygiene law to mandate that inpatient facilities dispense at least two doses of opioid reversal drugs to individuals at risk for a substance use disorder upon discharge. This applies to those with documented substance use disorders or those appearing at risk, ensuring they have access to necessary medications to prevent opioid overdoses. The bill aims to enhance patient safety and support recovery efforts by providing immediate access to life-saving drugs.